Patients who receive add-on cholesterol-lowering medication, ezetimibe, soon after a heart attack have a significantly better prognosis than those who receive the drug later or not at all. The corresponding…
Patients who receive add-on cholesterol-lowering medication, ezetimibe, soon after a heart attack have a significantly better prognosis than those who receive the drug later or not at all. The corresponding…